Home

STEVEN B RATOFF

CIK 1054941 · President and CEO · last filed 2023-03-09

STEVEN B RATOFF is a President and CEO who has filed 32 SEC Form 4 insider transactions across 2 companies since 2007. The most recent filing, for EGRX, was dated Mar 9, 2023. Across all open-market trades the lifetime net is −$458.3K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $4.1M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$4.14M

Companies

2

Total Filings

32

Lifetime Open-Market Net

-$458.3K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted Director 22,684 $2.14 $48.5K -$699.6K 16 2023-03-09
NVD Chief Executive Officer 823,866 $5.02 $4.14M $241.3K 13 2009-12-14

Recent Filings

32 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2023-03-09 EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted Grant (A) — $0 EDGAR
2022-03-02 EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted Grant (A) — $0 EDGAR
2021-04-12 EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted Exer (M) +7,020 $51.4K EDGAR
2021-04-07 EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted Exer (M) +2,340 $20.5K EDGAR
2021-02-04 EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted Grant (A) — $0 EDGAR
2020-01-07 EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted Grant (A) — $0 EDGAR
2019-03-06 EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted Exer (M) +2,340 $9.5K EDGAR
2019-01-25 EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted Grant (A) — $0 EDGAR
2018-01-09 EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted Grant (A) — $0 EDGAR
2017-12-20 EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted Exer (M) +2,340 $2.1K EDGAR
Showing 1–10 of 32
Page 1 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.